Advertisement
News
Subscribe to MDT Magazine News

Cardiac Network Announces Reverse Stock Split

May 6, 2011 12:35 am | by Bio-Medicine.Org | Comments

SAN FRANCISCO, May 5, 2011 /- Cardiac Network, Inc. (Other OTC: CNWI.PK) (the "Company") today announced that the Company will effect a 1-for-750 reverse stock split (the "Reverse Stock Split"). The Reverse Stock Split will take effect on the opening of business and trading on May 6, 2011...

TOPICS:

BD Launches BD MAXâ„¢ Open System in Europe and Reveals Strategy to Build Broad Menu of Assays that Provide Timely, Accurate Information to Laboratories and Clinicians

May 6, 2011 12:35 am | by Bio-Medicine.Org | Comments

MILAN, May 6, 2011 /- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX ), today announced the European launch of the BD MAX™ Open System for molecular testing, which will enable laboratories to run both laboratory and BD- developed assays and offer enhanced...

TOPICS:

Annual General Meeting of Active Biotech AB(2)

May 5, 2011 10:46 pm | by The Associated Press | Comments

The Annual General Meeting of Active Biotech was held on May 5, 2011.In accordance with the Board of Directors' proposal, it was resolved that no dividend would be paid.In accordance with the Election Committee's proposal, the Board members Mats Arnhog, Klas Karre, Magnhild Sandberg and Peter...

Advertisement

Annual General Meeting of Active Biotech AB

May 5, 2011 10:45 pm | Comments

The Annual General Meeting of Active Biotech was held on May 5, 2011.In accordance with the Board of Directors' proposal, it was resolved that no dividend would be paid.In accordance with the Election Committee's proposal, the Board members Mats Arnhog, Klas Karre, Magnhild Sandberg and Peter...

Novartis Gains FDA Approval for Afinitor® as First New Treatment in Nearly Three Decades for Patients with Advanced Pancreatic NET

May 5, 2011 5:35 pm | by Bio-Medicine.Org | Comments

EAST HANOVER, N.J., May 5, 2011 /- Novartis Pharmaceuticals Corporation ("Novartis") announced today that the US Food and Drug Administration (FDA) approved Afinitor® (everolimus) tablets for the treatment of progressive neuroendocrine tumors of pancreatic origin (PNET) in patients...

TOPICS:

PerkinElmer 1Q profit slips 4 percent(2)

May 5, 2011 4:46 pm | by The Associated Press | Comments

Health and industrial sciences company PerkinElmer Inc. said Thursday its profit fell 4 percent in the first quarter on charges related to businesses it has sold.PerkinElmer said its profit slipped to $23.5 million, or 20 cents per share, from $24.4 million, or 21 cents per share, a year ago....

Quidel to Present at Bank of America Merrill Lynch Health Care Conference

May 5, 2011 4:45 pm | by The Associated Press | Comments

Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cellular-based virology assays, announced today that it will present at the Bank of America Merrill Lynch Health Care Conference to be held at the Encore at Wynn hotel in Las Vegas, Nevada on...

Surgery reduces risk of mortality due to prostate cancer even for low-risk groups

May 5, 2011 2:37 pm | by EurekAlert | Comments

(Uppsala University) A Swedish research team partly consisting of researchers from Uppsala University followed a group of prostate cancer patients in the Nordic region for 15 years. The study found, among other things, that surgery reduces the risk that men with prostate cancer...

TOPICS:
Advertisement

Elsevier, Redfox Technologies and Microsoft launch innovative e-learning nursing solution

May 5, 2011 2:37 pm | by EurekAlert | Comments

(Elsevier) Elsevier, Redfox Technologies and Microsoft today announced the launch of the iCitizen Nursing Skills Netbook, an integrated and affordable e-learning netbook for nurses and nursing students in The Philippines.

TOPICS:

American Regent Initiates Nationwide Voluntary Recall of Caffeine & Sodium Benzoate Injection, USP 250 mg/mL, 2 mL Single Dose Vial Due to Visible Particulates

May 5, 2011 2:32 pm | by Bio-Medicine.Org | Comments

SHIRLEY, N.Y., May 5, 2011 /- American Regent is conducting a nationwide voluntary recall to the consumer and user level of the following product: Caffeine & Sodium Benzoate Injection, USP, 250 mg/mL, 2 mL Single Dose Vial, NDC # 0517-2502-10, Lot # 0084,  Exp Date...

TOPICS:

Power Wheelchairs Keep Medicare Beneficiaries Out of Nursing Homes, While Reducing Government Costs and Providing More Freedom and Independence

May 5, 2011 2:32 pm | by Bio-Medicine.Org | Comments

OCEANSIDE, Calif., May 5, 2011 /PRNewswire-USNewswire/ -- For Judith Talnadge, a power wheelchair provided through Medicare is the difference between living independently in her apartment, with opportunities to visit with friends and engage in the community, or being confined to a nursing...

TOPICS:

Advanced BioHealing plans $200M IPO

May 5, 2011 12:38 pm | by Mass High Tech: The Journal of New England Technology | Comments

Advanced BioHealing Inc., a Westport, Conn.-based developer of cell-based regenerative skin therapy, has filed terms of an initial public offering, for which it plans to raise about $200 million.

Xlumena Receives CE Mark for Revolutionary AXIOSâ„¢ Stent and Delivery System

May 5, 2011 11:36 am | by Bio-Medicine.Org | Comments

MOUNTAIN VIEW, Calif., May 5, 2011 /- Xlumena, Inc., a privately-held provider of innovative technology for the interventional endoscopist and endoscopic surgeon, announced today that it has received CE Mark approval for its revolutionary AXIOS™ Stent and Delivery System (AXIOS)....

TOPICS:

SCAI Releases Position Statement on Public Reporting and Risk Adjustment In Cardiovascular Quality Improvement Programs

May 5, 2011 11:34 am | by Bio-Medicine.Org | Comments

BALTIMORE, May 5, 2011 /- A new position statement released today by the Society for Cardiovascular Angiography and Interventions (SCAI) calls for changes in the way quality of percutaneous coronary intervention (PCI, also known as angioplasty) care is measured and publically reported....

TOPICS:

SCAI Announces National Quality Program to Improve Cardiovascular Patient Care

May 5, 2011 11:33 am | by Bio-Medicine.Org | Comments

BALTIMORE, May 5, 2011 /- Today at the Society for Cardiovascular Angiography and Interventions (SCAI) 2011 Scientific Sessions, SCAI announced its national quality improvement program to measure and improve quality in the cath lab for better patient care. Building on its legacy of using...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading